BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 1856485)

  • 1. A temperature-dependent rabbit model for production of dermal lesions by Haemophilus ducreyi.
    Purcell BK; Richardson JA; Radolf JD; Hansen EJ
    J Infect Dis; 1991 Aug; 164(2):359-67. PubMed ID: 1856485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of Haemophilus ducreyi bacteria, cytotoxin, endotoxin and antibodies in animal models for study of chancroid.
    Lagergård T
    Microb Pathog; 1992 Sep; 13(3):203-17. PubMed ID: 1291843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of protective immunity to Haemophilus ducreyi in the temperature-dependent rabbit model of experimental chancroid.
    Hansen EJ; Lumbley SR; Richardson JA; Purcell BK; Stevens MK; Cope LD; Datte J; Radolf JD
    J Immunol; 1994 Jan; 152(1):184-92. PubMed ID: 8254191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of skin adherence, penetration and tissue necrosis production by Haemophilus ducreyi, the causative agent of chancroid.
    Abeck D; Korting HC
    Acta Derm Venereol Suppl (Stockh); 1992; 174():1-20. PubMed ID: 1636361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cytolethal distending toxin of Haemophilus ducreyi aggravates dermal lesions in a rabbit model of chancroid.
    Wising C; Mölne L; Jonsson IM; Ahlman K; Lagergård T
    Microbes Infect; 2005 May; 7(5-6):867-74. PubMed ID: 15876546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune cells are required for cutaneous ulceration in a swine model of chancroid.
    San Mateo LR; Toffer KL; Orndorff PE; Kawula TH
    Infect Immun; 1999 Sep; 67(9):4963-7. PubMed ID: 10456960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo interactions of Haemophilus ducreyi with host phagocytes.
    Ahmed HJ; Johansson C; Svensson LA; Ahlman K; Verdrengh M; Lagergård T
    Infect Immun; 2002 Feb; 70(2):899-908. PubMed ID: 11796625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA protects against infection in the swine model of chancroid.
    Afonina G; Leduc I; Nepluev I; Jeter C; Routh P; Almond G; Orndorff PE; Hobbs M; Elkins C
    Infect Immun; 2006 Apr; 74(4):2224-32. PubMed ID: 16552053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiological concept of Haemophilus ducreyi infection (chancroid).
    Abeck D; Johnson AP
    Int J STD AIDS; 1992; 3(5):319-23. PubMed ID: 1391058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of humoral and cell-mediated inducible immunity to Haemophilus ducreyi in an animal model of chancroid.
    Desjardins M; Filion LG; Robertson S; Kobylinski L; Cameron DW
    Infect Immun; 1996 May; 64(5):1778-88. PubMed ID: 8613391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A humoral immune response confers protection against Haemophilus ducreyi infection.
    Cole LE; Toffer KL; Fulcher RA; San Mateo LR; Orndorff PE; Kawula TH
    Infect Immun; 2003 Dec; 71(12):6971-7. PubMed ID: 14638786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of lipooligosaccharides in experimental dermal lesions caused by Haemophilus ducreyi.
    Campagnari AA; Wild LM; Griffiths GE; Karalus RJ; Wirth MA; Spinola SM
    Infect Immun; 1991 Aug; 59(8):2601-8. PubMed ID: 1855979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Swine model of Haemophilus ducreyi infection.
    Hobbs MM; San Mateo LR; Orndorff PE; Almond G; Kawula TH
    Infect Immun; 1995 Aug; 63(8):3094-100. PubMed ID: 7622236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies directed against Haemophilus ducreyi heat shock proteins.
    Brown TJ; Jardine J; Ison CA
    Microb Pathog; 1993 Aug; 15(2):131-9. PubMed ID: 8255206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of skin lesions in mice following intradermal inoculation of Haemophilus ducreyi.
    Tuffrey M; Alexander F; Ballard RC; Taylor-Robinson D
    J Exp Pathol (Oxford); 1990 Apr; 71(2):233-44. PubMed ID: 2331407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of signature-tagged mutagenesis to identify virulence determinants in Haemophilus ducreyi responsible for ulcer formation.
    Yeung A; Cameron DW; Desjardins M; Lee BC
    J Microbiol Methods; 2011 Feb; 84(2):290-8. PubMed ID: 21185881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity and immunogenicity of purified Haemophilus ducreyi cytolethal distending toxin in a rabbit model.
    Wising C; Svensson LA; Ahmed HJ; Sundaeus V; Ahlman K; Jonsson IM; Mölne L; Lagergård T
    Microb Pathog; 2002 Aug; 33(2):49-62. PubMed ID: 12202104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of, antibody response to, and immunity induced by Haemophilus ducreyi hemolysin.
    Dutro SM; Wood GE; Totten PA
    Infect Immun; 1999 Jul; 67(7):3317-28. PubMed ID: 10377108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin M and G antibody response in rabbits after experimental Haemophilus ducreyi infection.
    Müller F; Müller KH
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Apr; 268(2):238-44. PubMed ID: 3260705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemophilus ducreyi inhibits phagocytosis by U-937 cells, a human macrophage-like cell line.
    Wood GE; Dutro SM; Totten PA
    Infect Immun; 2001 Aug; 69(8):4726-33. PubMed ID: 11447144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.